Alderaan Biotechnology raised €19M in a Series A round in Jan 2020. The company is based in Paris, France. Investors in the round: Advent France Biotechnology (AFB) and Medicxi. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €19M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
